🔎 Trials Near Me

Dachaigh › Cancer briste triple-negative › New Jersey › Edison

Sgrùdaidhean clionaigeach Cancer briste triple-negative ann an Edison, NJ

Tha aon sgrùdadh airson Cancer briste triple-negative a’ lorg phàirtichean aig làrach ann no faisg air Edison. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

A’ fastadhÌre 1
  • START New Jersey, East Brunswick · 6 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06270706

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

A’ fastadh
  • Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township · 5 mìle air falbh
Aoisean 30 agus nas sine · Banairean · Air ùrachadh 25 Sult 2026 · NCT02945579

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

A’ fastadhÌre 3
  • Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06966700

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

A’ fastadhÌre 1
  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06246968

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

A’ fastadhÌre 2
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT05570253

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

A’ fastadhÌre 3
  • Rutgers Health, New Brunswick · 3 mìle air falbh
  • Regional Cancer Care Associates LLC, East Brunswick · 6 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT05633654

A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer

A’ fastadhÌre 2
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mìle air falbh
Aoisean 70 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT07768436

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

A’ fastadhÌre 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT01042379

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

A’ fastadhÌre 2
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Gearr 2026 · NCT03808337

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

A’ fastadhÌre 2
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mìle air falbh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 17 Gearr 2026 · NCT04683679

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

A’ fastadhÌre 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Ògmh 2025 · NCT06568692

Sgrùdaidhean Cancer briste triple-negative ann am bailtean eile

Sgrùdaidhean eile ann an Edison

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.